What to expect from the FDA’s important COVID-19 vaccine meeting Thursday

Posted on AllSides December 9th, 2020
From The Center

An all-day regulatory meeting scheduled to take place Thursday is the next step toward the likely authorization of the first COVID-19 vaccine in the U.S.

The Food and Drug Administration this week plans to convene a meeting of its Vaccines and Related Biological Products Advisory Committee, which is made up of a group of independent medical experts, who will discuss the risks and benefits of BioNTech BNTX, -2.31% and Pfizer Inc.’s PFE, -2.07% experimental COVID-19 vaccine before voting on whether the FDA should authorize the vaccine. The regulator isn’t required...

Read full story

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right